NCT04198610

Brief Summary

The present clinico-biochemical study was carried out to estimate the levels of Fetuin A and MMP7 in serum of systemically healthy subjects in periodontal health and disease and to evaluate the impact of periodontal interventional therapy (scaling and root planing) on the same.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2017

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

February 26, 2019

Completed
10 months until next milestone

First Posted

Study publicly available on registry

December 13, 2019

Completed
Last Updated

December 13, 2019

Status Verified

February 1, 2019

Enrollment Period

6 months

First QC Date

February 26, 2019

Last Update Submit

December 11, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • estimate the change in levels of Fetuin A and MMP7 in serum at baseline and 3 months post SRP

    Serum was collected at baseline and 3 months and subjected to ELISA

    Serum collection at baseline and 3 months

Secondary Outcomes (5)

  • Modified Gingival index (GI)

    At baseline and 3 months

  • Relative Attachment level (RAL)

    At baseline and 3 months

  • Probing Depth (PD)

    At baseline and 3 months

  • Bleeding on Probing (BOP%)

    At baseline and 3 months

  • Plaque index (PI)

    At baseline and 3 months

Study Arms (3)

healthy

NO INTERVENTION

Ten patients with clinically healthy gingiva with probing depth less than 3mm and less than or equal to 10% sites with gingival bleeding on probing present.

chronic gingivitis

NO INTERVENTION

Chronic gingivitis was defined as having probing depth (PD) less than or equal to 4mm, relative attachment loss (RAL) ) less than or equal to 3mm and more than to 25% sites with gingival bleeding present (BOP)

chronic periodontitis

ACTIVE COMPARATOR

Chronic periodontitis was defined as having probing depth more than or equal to 5mm, RAL more than or equal to 8mm, with more than or equal to 10% sites with BOP positive and evidence of bone loss determined radiographically. Non surgical periodontal therapy (SRP) was concluded in 3 months. Within the duration of the study, all subjects received supportive therapy

Procedure: Non surgical periodontal therapy

Interventions

Procedure/Surgery: non surgical periodontal therapy and root planing (SRP) was performed in two to four appointments lasting approximately 60 minutes each under local anaesthesia (2% lignocaine hydrochloride with 1:2,00,000 adrenaline) using area specific Gracey periodontal curettes and an ultrasonic device. The treatment was concluded in 3 months. Within the duration of the study, all subjects received supportive therapy, which included professional plaque control and reinstruction of oral hygiene.

chronic periodontitis

Eligibility Criteria

Age30 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age group of 30-39 years.
  • Systemically healthy subjects.
  • Patient who are co-operative and able to attend follow up.
  • Patient who have not received any periodontal treatment within the past six months of baseline examination.
  • Dentition with at least 20 functional teeth.

You may not qualify if:

  • Medically compromised patients (history of diabetes mellitus, liver diseases, cardiovascular disease, kidney diseases, rheumatoid arthritis, bone diseases pulmonary disease, viral and fungal infections).
  • Patients with calcification disorders (chronic kidney disease with vascular calcification, hyperparathyroidism, excessive intake of vitamin D, valvular calcific aortic stenosis
  • Aggressive periodontitis.
  • Bleeding disorders
  • Gross oral pathology and suppuration
  • Patients who had received antibiotic therapy and anti inflammatory within the last six months.
  • Anomalies of the immune system.
  • Pregnancy and lactation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Krishnadevaraya college of dental sciences

Bangalore, Karnataka, 562157, India

Location

MeSH Terms

Conditions

GingivitisPeriodontal Diseases

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • BV Karthikeyan, MDS

    Krishnadevaraya college of Dental sciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2019

First Posted

December 13, 2019

Study Start

March 10, 2017

Primary Completion

August 28, 2017

Study Completion

August 28, 2017

Last Updated

December 13, 2019

Record last verified: 2019-02

Locations